Richard Geary
Corporate Officer/Principal bei IONIS PHARMACEUTICALS, INC.
Vermögen: 4 Mio $ am 31.03.2024
Profil
Richard S.
Geary is currently the Director at Oligonucleotide Therapeutics Society, Inc. and the Chief Development Officer & Executive VP at Ionis Pharmaceuticals, Inc. Previously, he worked as a Senior Research Scientist at Southwest Research Institute.
He completed his undergraduate degree at Texas A&M University and earned a doctorate from The University of Texas at Austin in 1987.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 29.02.2024 | 87 938 ( 0,06% ) | 4 Mio $ | 31.03.2024 |
Aktive Positionen von Richard Geary
| Unternehmen | Position | Beginn |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.08.2003 |
Oligonucleotide Therapeutics Society, Inc.
 Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The private company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Director/Board Member | - |
Ehemalige bekannte Positionen von Richard Geary
| Unternehmen | Position | Ende |
|---|---|---|
Southwest Research Institute
 Southwest Research Institute Miscellaneous Commercial ServicesCommercial Services Southwest Research Institute is a research and development organization. It offers technical services in engine design and development, emissions certification testing, fuels and lubricants. The firm provide services to automotive and transportation, biomedical and health, chemistry and materials, defence and security, electronics and automation, energy and environment, manufacturing and construction industries. The company was founded in 1947 and is headquartered in San Antonio, TX. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Richard Geary
| Texas A&M University | Undergraduate Degree |
| The University of Texas at Austin | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Southwest Research Institute
Southwest Research Institute Miscellaneous Commercial ServicesCommercial Services Southwest Research Institute is a research and development organization. It offers technical services in engine design and development, emissions certification testing, fuels and lubricants. The firm provide services to automotive and transportation, biomedical and health, chemistry and materials, defence and security, electronics and automation, energy and environment, manufacturing and construction industries. The company was founded in 1947 and is headquartered in San Antonio, TX. | Commercial Services |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The private company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Commercial Services |
